Cyclic pressure and shear stress regulate matrix metalloproteinases and cathepsin activity in porcine aortic valves

Journal of Heart Valve Disease

Volumn 15, Issue 5, 2006, Pages 622-629

  Platt, Manu O ^a   Xing, Yun ^b   Jo, Hanjoong ^a,b   Yoganathan, Ajit P ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CATHEPSIN L; CYSTEINE PROTEINASE; GELATINASE A; GELATINASE B;

ANIMAL; ANIMAL MODEL; AORTA VALVE; ARTICLE; DOWN REGULATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METABOLISM; PRESSURE; SHEAR STRENGTH; SWINE; UPREGULATION;

ANIMALS; AORTIC VALVE; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; DOWN-REGULATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MODELS, ANIMAL; PRESSURE; SHEAR STRENGTH; SWINE; UP-REGULATION;

EID: 39049176964     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Weber KT, Sun Y, Katwa LC, Cleutjens JP, Zhou G. Connective tissue and repair in the heart. Potential regulatory mechanisms. Ann N Y Acad Sci 1995;752:286-299
2. Schneider PJ, Deck JD. Tissue and cell renewal in the natural aortic valve of rats: An autoradiographic study. Cardiovasc Res 1981;15:181-189
3. Willems IE, Havenith MG, Smits JF, Daemen MJ. Structural alterations in heart valves during left ventricular pressure overload in the rat. Lab Invest 1994;71:127-133
4. Quick DW, Kunzelman KS, Kneebone JM, Cochran RP. Collagen synthesis is upregulated in mitral valves subjected to altered stress. Am Soc Artif Intern Organs J 1997;43:181-186
5. Butcher JT, Penrod AM, Garcia AJ, Nerem RM. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler Thromb Vasc Biol 2004;24:1429-1434
6. Simmons CA, Grant GR, Manduchi E, Davies PF. Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ Res 2005;96:792-799
7. Xing Y, He Z, Warnock JN, Hilbert SL, Yoganathan AP. Effects of constant static pressure on the biological properties of porcine aortic valve leaflets. Ann Biomed Eng 2004;32:555-562
8. Xing Y, Warnock JN, He Z, Hilbert SL, Yoganathan AP. Cyclic pressure affects the biological properties of porcine aortic valve leaflets in a magnitude and frequency dependent manner. Ann Biomed Eng 2004;32:1461-1470
9. Goulet B, Baruch A, Moon NS, et al. A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. Mol Cell 2004;14:207-219
10. Keyszer GM, Heer AH, Kriegsmann J, et al. Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization. Arthritis Rheum 1995;38:976-984
11. Taubert H, Riemann D, Kehlen A, et al. Expression of cathepsin B, D and L protein in juvenile idiopathic arthritis. Autoimmunity 2002;35:221-224
12. Rousselet N, Mills L, Jean D, Tellez C, Bar-Eli M, Frade R. Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment. Cancer Res 2004;64:146-151
13. Liu J, Sukhova GK, Yang JT, et al. Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis 2006;184:302-311
14. Stypmann J, Glaser K, Roth W, et al. Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L. Proc Natl Acad Sci USA 2002;99:6234-6239
15. Platt MO, Ankeny RF, Jo H. Laminar shear stress inhibits cathepsin L activity in endothelial cells. Arterioscler Thromb Vasc Biol 2006; http://atvb.ahajournals.org/cgi/reprint/01.ATV.0000227470.72109.2bv1
16. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998;102:576-583
17. Sukhova GK, Zhang Y, Pan JH, et al. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2003;111:897-906
18. Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Schoen FJ. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 2001;104:2525-2532
19. Berceli SA, Jiang Z, Klingman NV, et al. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling. J Vasc Surg 2004;39:1084-1090
20. Galis ZS, Johnson C, Godin D, et al. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 2002;91:852-859
21. Lessner SM, Martinson DE, Galis ZS. Compensatory vascular remodeling during atherosclerotic lesion growth depends on matrix metalloproteinase-9 activity. Arterioscler Thromb Vasc Biol 2004;24:2123-2129
22. Dreger SA, Taylor PM, Allen SP, Yacoub MH. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves. J Heart Valve Dis 2002;11:875-880;discussion 880
23. Soini Y, Satta J, Maatta M, Autio-Harmainen H. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. J Pathol 2001;194:225-231
24. Weston MW, Yoganathan AP. Biosynthetic activity in heart valve leaflets in response to in vitro flow environments. Ann Biomed Eng 2001;29:752-763
25. Desmazes C, Gauthier F, Lalmanach G. Cathepsin L, but not cathepsin B, is a potential kininogenase. Biol Chem 2001;382:811-815
26. Barrett AJ, Kirschke H. Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol 1981;80(Pt.C):535-561
27. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 2002;90:251-262
28. Lehoux S, Lemarie CA, Esposito B, Lijnen HR, Tedgui A. Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling. Circulation 2004;109:1041-1047
29. Bracher M, Simionescu D, Simionescu A, Davies N, Human P, Zilla P. Matrix metalloproteinases and tissue valve degeneration. J Long Term Eff Med Implants 2001;11:221-230
30. Edep ME, Shirani J, Wolf P, Brown DL. Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol 2000;9:281-286
31. Koullias GJ, Korkolis DP, Ravichandran P, Psyrri A, Hatzaras I, Elefteriades JA. Tissue microarray detection of matrix metalloproteinases, in diseased tricuspid and bicuspid aortic valves with or without pathology of the ascending aorta. Eur J Cardiothorac Surg 2004;26:1098-1103
32. Magid R, Murphy TJ, Galis ZS. Expression of matrix metalloproteinase-9 in endothelial cells is differentially regulated by shear stress. Role of c-Myc. J Biol Chem 2003;278:32994-32999
33. Mehrabian M, Demer LL, Lusis AJ. Differential accumulation of intimal monocyte-macrophages relative to lipoproteins and lipofuscin corresponds to hemodynamic forces on cardiac valves in mice. Arterioscler Thromb 1991;11:947-957